Patterson Companies, Inc. (0KGB.L)
USD 31.33
(1.57%)
USD 31.33
(1.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 374.75 Million USD | -2.95% |
| 2023 | 386.13 Million USD | 45.28% |
| 2022 | 367.17 Million USD | -12.0% |
| 2021 | 301.74 Million USD | 45.3% |
| 2020 | -476.89 Million USD | -8.77% |
| 2019 | 225.75 Million USD | -26.19% |
| 2018 | 307.01 Million USD | -17.98% |
| 2017 | 374.95 Million USD | -12.99% |
| 2016 | 431.32 Million USD | 1.51% |
| 2015 | 427.69 Million USD | 7.3% |
| 2014 | 398.61 Million USD | -1.22% |
| 2013 | 403.51 Million USD | 0.29% |
| 2012 | 402.36 Million USD | -8.02% |
| 2011 | 423.06 Million USD | 6.44% |
| 2010 | 404.2 Million USD | 9.15% |
| 2009 | 380.14 Million USD | 0.56% |
| 2008 | 374.46 Million USD | 6.07% |
| 2007 | 361.19 Million USD | 4.03% |
| 2006 | 339.35 Million USD | 5.21% |
| 2005 | 322.54 Million USD | 26.34% |
| 2004 | 242.5 Million USD | 38.59% |
| 2003 | 178.94 Million USD | 17.84% |
| 2002 | 160.57 Million USD | 24.18% |
| 2001 | 125.3 Million USD | 22.37% |
| 2000 | 106.76 Million USD | 21.59% |
| 1999 | 86.55 Million USD | 17.99% |
| 1998 | 72.72 Million USD | 28.49% |
| 1997 | 57.5 Million USD | 21.57% |
| 1996 | 47.7 Million USD | 12.78% |
| 1995 | 41.4 Million USD | 21.49% |
| 1994 | 33.8 Million USD | 61.06% |
| 1993 | 22 Million USD | 65.08% |
| 1992 | 14 Million USD | 28.57% |
| 1991 | 11.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 71.15 Million USD | -45.91% |
| 2024 FY | - USD | -11.98% |
| 2024 Q4 | 110.74 Million USD | 28.33% |
| 2024 Q3 | 95.48 Million USD | 11.96% |
| 2024 Q2 | 85.8 Million USD | 20.68% |
| 2023 Q2 | 81 Million USD | 47.23% |
| 2023 Q3 | 79.01 Million USD | -2.46% |
| 2023 Q1 | 55.02 Million USD | -36.14% |
| 2023 FY | - USD | 45.28% |
| 2023 Q4 | 131.26 Million USD | 66.12% |
| 2022 Q1 | -17.58 Million USD | -128.41% |
| 2022 FY | - USD | -12.0% |
| 2022 Q4 | 86.15 Million USD | 6.03% |
| 2022 Q3 | 81.25 Million USD | -2.48% |
| 2022 Q2 | 83.32 Million USD | 573.74% |
| 2021 FY | - USD | 45.3% |
| 2021 Q1 | 60.96 Million USD | -12.76% |
| 2021 Q4 | 61.91 Million USD | -6.19% |
| 2021 Q3 | 66 Million USD | -30.91% |
| 2021 Q2 | 95.52 Million USD | 56.69% |
| 2020 Q4 | 69.88 Million USD | 51.53% |
| 2020 Q2 | 4.54 Million USD | -93.44% |
| 2020 FY | - USD | -8.77% |
| 2020 Q1 | 69.22 Million USD | 4.05% |
| 2020 Q3 | 46.12 Million USD | 915.03% |
| 2019 Q1 | 26.62 Million USD | -58.16% |
| 2019 FY | - USD | -26.19% |
| 2019 Q2 | 68.22 Million USD | 156.26% |
| 2019 Q3 | 46.79 Million USD | -31.42% |
| 2019 Q4 | 66.52 Million USD | 42.18% |
| 2018 Q3 | 73.09 Million USD | -21.95% |
| 2018 Q1 | 79.44 Million USD | -32.64% |
| 2018 Q2 | 93.64 Million USD | 17.87% |
| 2018 Q4 | 63.62 Million USD | -12.95% |
| 2018 FY | - USD | -17.98% |
| 2017 Q2 | 103.07 Million USD | 16.94% |
| 2017 FY | - USD | -12.99% |
| 2017 Q4 | 117.95 Million USD | 71.95% |
| 2017 Q3 | 68.59 Million USD | -33.45% |
| 2017 Q1 | 88.13 Million USD | -32.97% |
| 2016 FY | - USD | 1.51% |
| 2016 Q4 | 131.5 Million USD | 12.42% |
| 2016 Q2 | 107.57 Million USD | 37.74% |
| 2016 Q3 | 116.97 Million USD | 8.74% |
| 2016 Q1 | 78.09 Million USD | -35.72% |
| 2015 Q3 | 103.28 Million USD | -1.8% |
| 2015 Q2 | 105.17 Million USD | 7.6% |
| 2015 Q4 | 121.48 Million USD | 17.62% |
| 2015 FY | - USD | 7.3% |
| 2015 Q1 | 97.74 Million USD | -9.12% |
| 2014 Q4 | 107.55 Million USD | -2.94% |
| 2014 Q2 | 88.53 Million USD | -3.45% |
| 2014 Q1 | 91.7 Million USD | -21.95% |
| 2014 FY | - USD | -1.22% |
| 2014 Q3 | 110.82 Million USD | 25.17% |
| 2013 Q3 | 102.31 Million USD | 15.0% |
| 2013 Q2 | 88.96 Million USD | -6.11% |
| 2013 Q1 | 94.75 Million USD | -17.81% |
| 2013 FY | - USD | 0.29% |
| 2013 Q4 | 117.48 Million USD | 14.83% |
| 2012 FY | - USD | -8.02% |
| 2012 Q1 | 96.21 Million USD | -20.01% |
| 2012 Q2 | 94.61 Million USD | -1.66% |
| 2012 Q3 | 101.85 Million USD | 7.65% |
| 2012 Q4 | 115.28 Million USD | 13.19% |
| 2011 Q3 | 104.06 Million USD | -2.27% |
| 2011 Q1 | 101.8 Million USD | -3.04% |
| 2011 Q2 | 106.48 Million USD | 4.59% |
| 2011 Q4 | 120.27 Million USD | 15.57% |
| 2011 FY | - USD | 6.44% |
| 2010 Q4 | 104.99 Million USD | -2.44% |
| 2010 Q1 | 88.1 Million USD | -11.49% |
| 2010 FY | - USD | 9.15% |
| 2010 Q3 | 107.62 Million USD | 9.76% |
| 2010 Q2 | 98.05 Million USD | 11.29% |
| 2009 Q3 | 99.98 Million USD | 9.53% |
| 2009 FY | - USD | 0.56% |
| 2009 Q1 | 85.75 Million USD | -12.85% |
| 2009 Q2 | 91.28 Million USD | 6.44% |
| 2009 Q4 | 99.54 Million USD | -0.44% |
| 2008 FY | - USD | 6.07% |
| 2008 Q1 | 80.53 Million USD | -19.8% |
| 2008 Q2 | 91.21 Million USD | 13.25% |
| 2008 Q3 | 104.31 Million USD | 14.37% |
| 2008 Q4 | 98.4 Million USD | -5.67% |
| 2007 Q4 | 100.42 Million USD | 2.99% |
| 2007 Q1 | 74.76 Million USD | -22.51% |
| 2007 Q2 | 82.3 Million USD | 10.09% |
| 2007 FY | - USD | 4.03% |
| 2007 Q3 | 97.5 Million USD | 18.46% |
| 2006 Q4 | 96.47 Million USD | 3.3% |
| 2006 Q3 | 93.39 Million USD | 21.68% |
| 2006 Q2 | 76.75 Million USD | 5.53% |
| 2006 Q1 | 72.72 Million USD | -16.86% |
| 2006 FY | - USD | 5.21% |
| 2005 FY | - USD | 26.34% |
| 2005 Q4 | 87.47 Million USD | 0.36% |
| 2005 Q3 | 87.16 Million USD | 15.88% |
| 2005 Q2 | 75.21 Million USD | 3.48% |
| 2005 Q1 | 72.68 Million USD | -1.91% |
| 2004 FY | - USD | 38.59% |
| 2004 Q4 | 74.1 Million USD | 1.57% |
| 2004 Q2 | 58.58 Million USD | 26.33% |
| 2004 Q3 | 72.96 Million USD | 24.54% |
| 2004 Q1 | 46.37 Million USD | -0.43% |
| 2003 FY | - USD | 17.84% |
| 2003 Q1 | 42.12 Million USD | -11.39% |
| 2003 Q2 | 45.79 Million USD | 8.1% |
| 2003 Q3 | 49.74 Million USD | 12.55% |
| 2003 Q4 | 54.05 Million USD | -6.17% |
| 2002 Q1 | 32.17 Million USD | -20.89% |
| 2002 Q4 | 46.67 Million USD | 11.92% |
| 2002 Q3 | 42.01 Million USD | 6.37% |
| 2002 Q2 | 39.71 Million USD | 26.97% |
| 2002 FY | - USD | 24.18% |
| 2001 Q3 | 33.25 Million USD | 3.83% |
| 2001 Q2 | 31.6 Million USD | 18.21% |
| 2001 FY | - USD | 22.37% |
| 2001 Q1 | 26.72 Million USD | -9.96% |
| 2001 Q4 | 41.27 Million USD | 22.4% |
| 2000 Q1 | 24.4 Million USD | 2.64% |
| 2000 Q4 | 29.94 Million USD | 5.41% |
| 2000 Q2 | 24.83 Million USD | 1.29% |
| 2000 FY | - USD | 21.59% |
| 2000 Q3 | 28.3 Million USD | 14.41% |
| 1999 Q2 | 20.7 Million USD | 12.71% |
| 1999 Q1 | 18.4 Million USD | -10.4% |
| 1999 Q4 | 23.5 Million USD | -2.58% |
| 1999 Q3 | 23.8 Million USD | 14.22% |
| 1999 FY | - USD | 17.99% |
| 1998 Q1 | 15.3 Million USD | -13.61% |
| 1998 Q3 | 19.1 Million USD | 8.67% |
| 1998 Q2 | 17.6 Million USD | 18.49% |
| 1998 FY | - USD | 28.49% |
| 1998 Q4 | 20.6 Million USD | 7.45% |
| 1997 Q4 | 17 Million USD | 6.96% |
| 1997 Q2 | 13.9 Million USD | 40.66% |
| 1997 Q1 | 9.7 Million USD | -36.36% |
| 1997 FY | - USD | 21.57% |
| 1997 Q3 | 16.3 Million USD | 23.44% |
| 1996 Q4 | 14.1 Million USD | 38.83% |
| 1996 FY | - USD | 12.78% |
| 1996 Q3 | 11 Million USD | -8.04% |
| 1996 Q2 | 11.8 Million USD | 15.46% |
| 1996 Q1 | 10.2 Million USD | -17.8% |
| 1995 Q2 | 9.9 Million USD | 7.95% |
| 1995 Q3 | 10.3 Million USD | 8.42% |
| 1995 Q4 | 12.1 Million USD | 14.56% |
| 1995 FY | - USD | 21.49% |
| 1995 Q1 | 8.9 Million USD | -16.98% |
| 1994 Q3 | 8.4 Million USD | 0.0% |
| 1994 Q4 | 10 Million USD | 30.86% |
| 1994 FY | - USD | 61.06% |
| 1994 Q1 | 7 Million USD | 45.65% |
| 1994 Q2 | 8.4 Million USD | 20.9% |
| 1993 Q4 | 5.6 Million USD | -6.12% |
| 1993 FY | - USD | 65.08% |
| 1993 Q1 | 81.9 Million USD | 143.43% |
| 1993 Q2 | 5.1 Million USD | -93.77% |
| 1993 Q3 | 5 Million USD | -3.92% |
| 1992 Q4 | -188.6 Million USD | -373.33% |
| 1992 FY | - USD | 28.57% |
| 1992 Q1 | 63.3 Million USD | 138.09% |
| 1992 Q2 | 69.8 Million USD | 10.27% |
| 1992 Q3 | 69 Million USD | -1.15% |
| 1991 FY | - USD | 0.0% |
| 1991 Q1 | 57.4 Million USD | 0.0% |
| 1991 Q2 | 60.6 Million USD | 5.57% |
| 1991 Q3 | 59.6 Million USD | -1.65% |
| 1991 Q4 | -166.2 Million USD | -378.86% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 464.035% |
| Accuray Incorporated | 9 Million USD | -4059.796% |
| Align Technology, Inc. | 799.03 Million USD | 53.099% |
| Elevance Health Inc. | 10.49 Billion USD | 96.427% |
| AxoGen, Inc. | -13.32 Million USD | 2911.795% |
| Boston Scientific Corporation | 3.61 Billion USD | 89.628% |
| CVS Health Corporation | 18.17 Billion USD | 97.938% |
| Cardinal Health, Inc. | 1.97 Billion USD | 81.054% |
| Centene Corporation | -463 Million USD | 180.941% |
| DaVita Inc. | 2.34 Billion USD | 84.029% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 97.054% |
| Hologic, Inc. | 1.29 Billion USD | 71.088% |
| Humana Inc. | -561 Million USD | 166.801% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 69.223% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 72.228% |
| Masimo Corporation | 236.7 Million USD | -58.325% |
| McKesson Corporation | 4.66 Billion USD | 91.97% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 78.363% |
| ResMed Inc. | 1.6 Billion USD | 76.583% |
| Henry Schein, Inc. | 943 Million USD | 60.259% |
| Teladoc Health, Inc. | 153.99 Million USD | -143.353% |
| Universal Health Services, Inc. | 1.74 Billion USD | 78.505% |
| Veeva Systems Inc. | 429.33 Million USD | 12.712% |
| Baxter International Inc. | 2.77 Billion USD | 86.5% |
| Becton, Dickinson and Company | 4.27 Billion USD | 91.234% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 84.347% |
| Danaher Corporation | 7.49 Billion USD | 95.003% |
| Stryker Corporation | 5.16 Billion USD | 92.737% |
| Medtronic plc | 9.05 Billion USD | 95.862% |